FDMT Market Cap from 2010 to 2024

FDMT Stock  USD 7.84  0.03  0.38%   
4D Molecular Market Cap yearly trend continues to be comparatively stable with very little volatility. Market Cap will likely drop to about 577.8 M in 2024. From the period from 2010 to 2024, 4D Molecular Market Cap quarterly data regression had r-value of  0.35 and coefficient of variation of  26.96. View All Fundamentals
 
Market Cap  
First Reported
2010-12-31
Previous Quarter
792.8 M
Current Value
577.8 M
Quarterly Volatility
183.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check 4D Molecular financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among 4D Molecular's main balance sheet or income statement drivers, such as Net Interest Income of 9.6 M, Interest Income of 9.6 M or Depreciation And Amortization of 4.2 M, as well as many indicators such as Price To Sales Ratio of 36.34, Dividend Yield of 0.0 or PTB Ratio of 2.7. FDMT financial statements analysis is a perfect complement when working with 4D Molecular Valuation or Volatility modules.
  
Check out the analysis of 4D Molecular Correlation against competitors.

Latest 4D Molecular's Market Cap Growth Pattern

Below is the plot of the Market Cap of 4D Molecular Therapeutics over the last few years. It is 4D Molecular's Market Cap historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in 4D Molecular's overall financial position and show how it may be relating to other accounts over time.
Market Cap10 Years Trend
Slightly volatile
   Market Cap   
       Timeline  

FDMT Market Cap Regression Statistics

Arithmetic Mean681,538,252
Geometric Mean663,138,274
Coefficient Of Variation26.96
Mean Deviation132,943,888
Median600,831,392
Standard Deviation183,752,608
Sample Variance33765T
Range599M
R-Value0.35
Mean Square Error31876.1T
R-Squared0.12
Significance0.20
Slope14,432,189
Total Sum of Squares472710.3T

FDMT Market Cap History

2024577.8 M
2023792.8 M
2022718.5 M
2021608.4 M
20191.1 B
2018507 M

About 4D Molecular Financial Statements

4D Molecular shareholders use historical fundamental indicators, such as Market Cap, to determine how well the company is positioned to perform in the future. Although 4D Molecular investors may analyze each financial statement separately, they are all interrelated. The changes in 4D Molecular's assets and liabilities, for example, are also reflected in the revenues and expenses on on 4D Molecular's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Market Cap792.8 M577.8 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for FDMT Stock Analysis

When running 4D Molecular's price analysis, check to measure 4D Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4D Molecular is operating at the current time. Most of 4D Molecular's value examination focuses on studying past and present price action to predict the probability of 4D Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4D Molecular's price. Additionally, you may evaluate how the addition of 4D Molecular to your portfolios can decrease your overall portfolio volatility.